Cohort of patients with suspected primary Sjögren syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the diagnostic performance of various classification criteria for primary Sjögren syndrome (pSS) against a gold standard established by expert physicians. It is a single-center, prospective intervention that will collect clinical, biological, and imaging data from patients suspected of having pSS. Participants will be monitored over a period of up to 10 years, with samples of blood, fluid, cells, and urine collected at specified intervals. Additionally, non-Sjögren controls will also be followed to compare findings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Major patient
* Suspicion of SSp (clinical or biological criteria, i.e. dry eye or oral syndrome, arthritis, parotidomegaly, neuropathy, kidney or lung disease...)
* Patient affiliated with Social Security
* Patient who has signed written informed consent

Exclusion Criteria:

* Refusal to participate
* Pregnant and lactating woman

Where it's running

• CHRU de Brest
  Brest, France Recruiting

Study contacts

• Principal investigator: Valérie Devauchelle — Chru Brest
• Study coordinator: Valérie Devauchelle, MD,PhD
• Email: valerie.devauchelle-pensec@chu-brest.fr
• Phone: 33 (0) 2 98 34 72 64

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people

  This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07829497

• First-in-human test of CND319 in healthy people and people with rheumatic diseases

  This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.

  Recruiting Phase 1 Candid Therapeutics · Melbourne, Victoria · NCT07712939

• Tofacitinib safety for people with primary Sjogren disease

  This study will test whether the oral pill tofacitinib is safe and tolerable for adults with primary Sjogren disease and mild-to-moderate symptoms.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07281456

• YTS109 cell therapy for relapsed or refractory autoimmune diseases

  This will try a single infusion of YTS109 immune cells to see if they are safe and help adults 18–65 with relapsed or refractory lupus (including lupus nephritis), Sjogren's syndrome, inflammatory myopathy, or ANCA‑associated vasculitis.

  Recruiting Phase 1 China Immunotech (Beijing) Biotechnology Co., Ltd. · Bengbu · NCT07236762

• Creating Health online course for people with rheumatological conditions

  This project will test whether an online course about diet and self-care helps adults with rheumatoid arthritis, Sjogren's syndrome, lupus, mixed connective tissue disease, or psoriatic arthritis reduce fatigue and improve quality of life.

  Recruiting University of Iowa · Iowa City, Iowa · NCT07180537

• 68Ga-FAPI PET-CT to image inflammation in Sjögren's syndrome

  This trial will test whether 68Ga-FAPI PET-CT can show active inflammation in adults with Sjögren's syndrome compared with tumor patients.

  Recruiting Phase 1/2 Peking Union Medical College Hospital · Beijing · NCT07062523

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.